|
|
Volumn 142, Issue 5, 2012, Pages 1253-1254
|
|
Interferon-free oral therapy for hepatitis C: "faraway, so close!"
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALISPORIVIR;
ANTIVIRUS AGENT;
ASUNAPREVIR;
BALAPIRAVIR;
BOCEPREVIR;
DACLATASVIR;
MEROPENEM;
PEGINTERFERON;
RIBAVIRIN;
TEGOBUVIR;
TELAPREVIR;
VALOPICITABINE;
VIRUS RNA;
AGEUSIA;
ANTIVIRAL ACTIVITY;
ANTIVIRAL RESISTANCE;
ANTIVIRAL THERAPY;
BILIRUBIN BLOOD LEVEL;
DIARRHEA;
DRUG EFFICACY;
DRUG ERUPTION;
DRUG FEVER;
DRUG POTENCY;
DRUG SAFETY;
FOLLOW UP;
GASTROENTERITIS;
GASTROINTESTINAL SYMPTOM;
GENOTYPE;
HEADACHE;
HEPATITIS C;
HEPATITIS C VIRUS;
HIGH THROUGHPUT SCREENING;
HUMAN;
LIFE CYCLE STAGE;
LIMIT OF QUANTITATION;
LYMPHOCYTOPENIA;
NEUTROPENIA;
NONHUMAN;
NOTE;
PRIORITY JOURNAL;
SIDE EFFECT;
TREATMENT DURATION;
TREATMENT FAILURE;
TREATMENT RESPONSE;
ULCERATIVE COLITIS;
X RAY CRYSTALLOGRAPHY;
|
|
EID: 84860137068
PISSN: 00165085
EISSN: 15280012
Source Type: Journal
DOI: 10.1053/j.gastro.2012.03.018 Document Type: Note |
|
Times cited : (2)
|
|
References (0)
|
